{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:05:33Z","timestamp":1791295533279,"version":"4.1.0"},"reference-count":90,"publisher":"Portland Press Ltd.","issue":"3","license":[{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,26]]},"abstract":"<jats:p>Pulmonary arterial hypertension (PAH) is a rare and life-threatening vascular disorder, characterised by abnormal remodelling of the pulmonary vessels and elevated pulmonary artery pressure, leading to right ventricular hypertrophy and right-sided heart failure. The importance of bone morphogenetic protein (BMP) signalling in the pathogenesis of PAH is demonstrated by human genetic studies. Many PAH risk genes are involved in the BMP signalling pathway and are highly expressed or preferentially act on vascular endothelial cells. Endothelial dysfunction is recognised as an initial trigger for PAH, and endothelial BMP signalling plays a crucial role in the maintenance of endothelial integrity. BMPR2 is the most prevalent PAH gene, found in over 80% of heritable cases. As BMPRII protein is the major type II receptor for a large family of BMP ligands and expressed ubiquitously in many tissues, dysregulated BMP signalling in other cells may also contribute to PAH pathobiology. Sotatercept, which contains the extracellular domain of another transforming growth factor-\u03b2 family type II receptor ActRIIA fused to immunoglobin Fc domain, was recently approved by the FDA as a treatment for PAH. Neither its target cells nor its mechanism of action is fully understood. This review will revisit BMPRII function and its extracellular regulation, summarise how dysregulated BMP signalling in endothelial cells and smooth muscle cells may contribute to PAH pathogenesis, and discuss how novel therapeutics targeting the extracellular regulation of BMP signalling, such as BMP9 and Sotatercept, can be related to restoring BMPRII function.<\/jats:p>","DOI":"10.1042\/bst20231547","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T11:40:05Z","timestamp":1715168405000},"page":"1515-1528","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Bone morphogenetic protein signalling in pulmonary arterial hypertension: revisiting the BMPRII connection"],"prefix":"10.1042","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1924-3120","authenticated-orcid":false,"given":"Wei","family":"Li","sequence":"first","affiliation":[{"name":"VPD Heart and Lung Research Institute, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0BB, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Quigley","sequence":"additional","affiliation":[{"name":"VPD Heart and Lung Research Institute, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0BB, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2024,5,8]]},"reference":[{"key":"2024062609405458900_BST-2023-1547CC1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2024062609405458900_BST-2023-1547CC2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1183\/09031936.00092306","article-title":"An epidemiological study of pulmonary arterial hypertension","volume":"30","year":"2007","journal-title":"Eur. Respir. J."},{"key":"2024062609405458900_BST-2023-1547CC3","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1172\/JCI60658","article-title":"Molecular pathogenesis of pulmonary arterial hypertension","volume":"122","year":"2012","journal-title":"J. Clin. Invest."},{"key":"2024062609405458900_BST-2023-1547CC4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrcardio.2017.84","article-title":"Epidemiology and treatment of pulmonary arterial hypertension","volume":"14","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"2024062609405458900_BST-2023-1547CC5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41569-019-0242-x","article-title":"Molecular genetic framework underlying pulmonary arterial hypertension","volume":"17","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"2024062609405458900_BST-2023-1547CC6","doi-asserted-by":"publisher","first-page":"201471","DOI":"10.1183\/13993003.01471-2022","article-title":"Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH","volume":"61","year":"2023","journal-title":"Eur. Respir. J."},{"key":"2024062609405458900_BST-2023-1547CC7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S2213-2600(15)00544-5","article-title":"BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis","volume":"4","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"2024062609405458900_BST-2023-1547CC8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1183\/13993003.00717-2015","article-title":"Genetic counselling in a national referral centre for pulmonary hypertension","volume":"47","year":"2016","journal-title":"Eur. Respir. J."},{"key":"2024062609405458900_BST-2023-1547CC9","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/humu.22904","article-title":"Pulmonary arterial hypertension: a current perspective on established and emerging molecular genetic defects","volume":"36","year":"2015","journal-title":"Hum. Mutat."},{"key":"2024062609405458900_BST-2023-1547CC10","doi-asserted-by":"publisher","first-page":"100925","DOI":"10.1016\/j.gim.2023.100925","article-title":"Defining the clinical validity of genes reported to cause pulmonary arterial hypertension","volume":"25","year":"2023","journal-title":"Genet Med."},{"key":"2024062609405458900_BST-2023-1547CC11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/B978-0-12-821618-7.00246-7","volume-title":"Encyclopedia of Cell Biology","year":"2022","edition":"2nd edn"},{"key":"2024062609405458900_BST-2023-1547CC12","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1164\/rccm.201205-0886OC","article-title":"Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension","volume":"186","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2024062609405458900_BST-2023-1547CC13","doi-asserted-by":"publisher","first-page":"e176379","DOI":"10.1172\/JCI176379","article-title":"Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances","volume":"134","year":"2024","journal-title":"J. Clin. Invest."},{"key":"2024062609405458900_BST-2023-1547CC14","first-page":"46","volume-title":"Encyclopedia of Cell Biology","year":"2023","edition":"2nd edn"},{"key":"2024062609405458900_BST-2023-1547CC15","doi-asserted-by":"publisher","first-page":"a022103","DOI":"10.1101\/cshperspect.a022103","article-title":"Structural biology and evolution of the TGF-beta family","volume":"8","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2024062609405458900_BST-2023-1547CC16","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1042\/BST20200663","article-title":"The role of pro-domains in human growth factors and cytokines","volume":"49","year":"2021","journal-title":"Biochem. Soc. Trans."},{"key":"2024062609405458900_BST-2023-1547CC17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cytogfr.2020.09.003","article-title":"Receptor binding competition: a paradigm for regulating TGF-beta family action","volume":"57","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"2024062609405458900_BST-2023-1547CC18","doi-asserted-by":"publisher","first-page":"2301634","DOI":"10.1183\/13993003.01634-2023","article-title":"Pulmonary vascular phenotype identified in patients with GDF2 (BMP9) or BMP10 variants: an international multicentre study","volume":"63","year":"2024","journal-title":"Eur. Respir. J."},{"key":"2024062609405458900_BST-2023-1547CC19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/01.CIR.0000102381.57477.50","article-title":"Endothelial dysfunction in pulmonary hypertension","volume":"109","year":"2004","journal-title":"Circulation"},{"key":"2024062609405458900_BST-2023-1547CC20","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cmet.2015.03.010","article-title":"BMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertension","volume":"21","year":"2015","journal-title":"Cell Metab."},{"key":"2024062609405458900_BST-2023-1547CC21","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.115.020617","article-title":"In pulmonary arterial hypertension, reduced BMPR2 promotes endothelial-to-mesenchymal transition via HMGA1 and its target slug","volume":"133","year":"2016","journal-title":"Circulation"},{"key":"2024062609405458900_BST-2023-1547CC22","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nm.3877","article-title":"Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension","volume":"21","year":"2015","journal-title":"Nat. Med."},{"key":"2024062609405458900_BST-2023-1547CC23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1161\/01.RES.0000200180.01710.e6","article-title":"Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension","volume":"98","year":"2006","journal-title":"Circ. Res."},{"key":"2024062609405458900_BST-2023-1547CC24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1182\/blood-2010-05-285973","article-title":"Bone morphogenetic protein receptor II regulates pulmonary artery endothelial cell barrier function","volume":"117","year":"2011","journal-title":"Blood"},{"key":"2024062609405458900_BST-2023-1547CC25","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1093\/hmg\/ddz047","article-title":"BMPRII deficiency impairs apoptosis via the BMPRII-ALK1-BclX-mediated pathway in pulmonary arterial hypertension","volume":"28","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"2024062609405458900_BST-2023-1547CC26","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1161\/CIRCULATIONAHA.107.736801","article-title":"Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension","volume":"118","year":"2008","journal-title":"Circulation"},{"key":"2024062609405458900_BST-2023-1547CC27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00018-011-0751-1","article-title":"BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain","volume":"69","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"2024062609405458900_BST-2023-1547CC28","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1074\/jbc.M115.683292","article-title":"The prodomain-bound form of bone morphogenetic protein 10 is biologically active on endothelial cells","volume":"291","year":"2016","journal-title":"J. Biol. Chem."},{"key":"2024062609405458900_BST-2023-1547CC29","doi-asserted-by":"publisher","first-page":"15794","DOI":"10.1074\/jbc.M109.002881","article-title":"Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells","volume":"284","year":"2009","journal-title":"J. Biol. Chem."},{"key":"2024062609405458900_BST-2023-1547CC30","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1164\/rccm.202005-1761OC","article-title":"Circulating BMP9 protects the pulmonary endothelium during inflammation-induced lung injury in mice","volume":"203","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2024062609405458900_BST-2023-1547CC31","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1038\/s41467-022-30111-2","article-title":"Crystal structures of BMPRII extracellular domain in binary and ternary receptor complexes with BMP10","volume":"13","year":"2022","journal-title":"Nat. Commun."},{"key":"2024062609405458900_BST-2023-1547CC32","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1161\/01.RES.0000166926.54293.68","article-title":"Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension","volume":"96","year":"2005","journal-title":"Circ. Res."},{"key":"2024062609405458900_BST-2023-1547CC33","doi-asserted-by":"publisher","first-page":"L312","DOI":"10.1152\/ajplung.00054.2013","article-title":"Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells","volume":"305","year":"2013","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"2024062609405458900_BST-2023-1547CC34","doi-asserted-by":"publisher","first-page":"24443","DOI":"10.1074\/jbc.M502825200","article-title":"Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells","volume":"280","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2024062609405458900_BST-2023-1547CC35","doi-asserted-by":"publisher","first-page":"14079","DOI":"10.1038\/ncomms14079","article-title":"TNFalpha drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling","volume":"8","year":"2017","journal-title":"Nat. Commun."},{"key":"2024062609405458900_BST-2023-1547CC36","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1164\/rccm.201408-1509OC","article-title":"Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension","volume":"192","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2024062609405458900_BST-2023-1547CC37","doi-asserted-by":"publisher","first-page":"L604","DOI":"10.1152\/ajplung.00309.2011","article-title":"BMP type II receptor deficiency confers resistance to growth inhibition by TGF-beta in pulmonary artery smooth muscle cells: role of proinflammatory cytokines","volume":"302","year":"2012","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"2024062609405458900_BST-2023-1547CC38","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1177\/2045893217729096","article-title":"Differential IL-1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodeling","volume":"7","year":"2017","journal-title":"Pulm. Circ."},{"key":"2024062609405458900_BST-2023-1547CC39","doi-asserted-by":"publisher","first-page":"4750","DOI":"10.1182\/blood-2011-05-347393","article-title":"Attenuation of leukocyte recruitment via CXCR1\/2 inhibition stops the progression of PAH in mice with genetic ablation of endothelial BMPR-II","volume":"118","year":"2011","journal-title":"Blood"},{"key":"2024062609405458900_BST-2023-1547CC40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1164\/rccm.202108-1919OC","article-title":"Autoimmunity is a significant feature of idiopathic pulmonary arterial hypertension","volume":"206","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2024062609405458900_BST-2023-1547CC41","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.tips.2021.04.002","article-title":"Targeting the TGF-beta signaling pathway for resolution of pulmonary arterial hypertension","volume":"42","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"2024062609405458900_BST-2023-1547CC42","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1093\/cvr\/cvaa350","article-title":"Approaches to treat pulmonary arterial hypertension by targeting BMPR2: from cell membrane to nucleus","volume":"117","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"2024062609405458900_BST-2023-1547CC43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.coph.2021.05.003","article-title":"Promising therapeutic approaches in pulmonary arterial hypertension","volume":"59","year":"2021","journal-title":"Curr. Opin. Pharmacol."},{"key":"2024062609405458900_BST-2023-1547CC44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/genes12010008","article-title":"Novel advances in modifying BMPR2 signaling in PAH","volume":"12","year":"2020","journal-title":"Genes (Basel)"},{"key":"2024062609405458900_BST-2023-1547CC45","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1165\/rcmb.2013-0100OC","article-title":"Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension","volume":"49","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2024062609405458900_BST-2023-1547CC46","doi-asserted-by":"publisher","first-page":"2045894020935783","DOI":"10.1177\/2045894020935783","article-title":"Targeting translational read-through of premature termination mutations in BMPR2 with PTC124 for pulmonary arterial hypertension","volume":"10","year":"2020","journal-title":"Pulm. Circ."},{"key":"2024062609405458900_BST-2023-1547CC47","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1165\/rcmb.2019-0321OC","article-title":"4PBA restores signaling of a cysteine-substituted mutant BMPR2 receptor found in patients with pulmonary arterial hypertension","volume":"63","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2024062609405458900_BST-2023-1547CC48","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1161\/CIRCRESAHA.111.300483","article-title":"Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation","volume":"112","year":"2013","journal-title":"Circ. Res."},{"key":"2024062609405458900_BST-2023-1547CC49","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1172\/JCI65592","article-title":"FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension","volume":"123","year":"2013","journal-title":"J. Clin. Invest."},{"key":"2024062609405458900_BST-2023-1547CC50","doi-asserted-by":"publisher","first-page":"1602449","DOI":"10.1183\/13993003.02449-2016","article-title":"Randomised placebo-controlled safety and tolerability trial of FK506 (tacrolimus) for pulmonary arterial hypertension","volume":"50","year":"2017","journal-title":"Eur. Respir. J."},{"key":"2024062609405458900_BST-2023-1547CC51","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/s41467-018-03672-4","article-title":"Identification of rare sequence variation underlying heritable pulmonary arterial hypertension","volume":"9","year":"2018","journal-title":"Nat. Commun."},{"key":"2024062609405458900_BST-2023-1547CC52","doi-asserted-by":"publisher","first-page":"1801609","DOI":"10.1183\/13993003.01609-2018","article-title":"Germline BMP9 mutation causes idiopathic pulmonary arterial hypertension","volume":"53","year":"2019","journal-title":"Eur. Respir. J."},{"key":"2024062609405458900_BST-2023-1547CC53","doi-asserted-by":"publisher","first-page":"1902165","DOI":"10.1183\/13993003.02165-2019","article-title":"Familial pulmonary arterial hypertension by KDR heterozygous loss of function","volume":"55","year":"2020","journal-title":"Eur. Respir. J."},{"key":"2024062609405458900_BST-2023-1547CC54","doi-asserted-by":"publisher","first-page":"e1685","DOI":"10.1002\/mgg3.1685","article-title":"Homozygous GDF2 nonsense mutations result in a loss of circulating BMP9 and BMP10 and are associated with either PAH or an \u201cHHT-like\u201d syndrome in children","volume":"9","year":"2021","journal-title":"Mol. Genet. Genomic Med."},{"key":"2024062609405458900_BST-2023-1547CC55","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/ajmg.a.62996","article-title":"A rare homozygous missense GDF2 (BMP9) mutation causing PAH in siblings: does BMP10 status contribute?","volume":"191","year":"2023","journal-title":"Am. J. Med. Genet. A"},{"key":"2024062609405458900_BST-2023-1547CC56","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1002\/ajmg.a.63236","article-title":"Pediatric pulmonary arterial hypertension due to a novel homozygous GDF2 missense variant affecting BMP9 processing and activity","volume":"191","year":"2023","journal-title":"Am. J. Med. Genet. A"},{"key":"2024062609405458900_BST-2023-1547CC57","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12890-016-0183-7","article-title":"Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: a case report","volume":"16","year":"2016","journal-title":"BMC Pulm. Med."},{"key":"2024062609405458900_BST-2023-1547CC58","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1161\/CIRCRESAHA.107.165530","article-title":"Bone morphogenetic protein-9 is a circulating vascular quiescence factor","volume":"102","year":"2008","journal-title":"Circ. Res."},{"key":"2024062609405458900_BST-2023-1547CC59","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1093\/hmg\/ddt216","article-title":"The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signalling in endothelial cells harbouring BMPR-II mutations","volume":"22","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"2024062609405458900_BST-2023-1547CC60","doi-asserted-by":"publisher","first-page":"eadi3275","DOI":"10.1126\/scitranslmed.adi3275","article-title":"Bone morphogenetic protein 9 is a candidate prognostic biomarker and host-directed therapy target for sepsis","volume":"16","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"2024062609405458900_BST-2023-1547CC61","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/CIRCRESAHA.118.313356","article-title":"Selective BMP-9 inhibition partially protects against experimental pulmonary hypertension","volume":"124","year":"2019","journal-title":"Circ. Res."},{"key":"2024062609405458900_BST-2023-1547CC62","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1093\/cvr\/cvab187","article-title":"Different cardiovascular and pulmonary phenotypes for single- and double-knock-out mice deficient in BMP9 and BMP10","volume":"118","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"2024062609405458900_BST-2023-1547CC63","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1161\/CIRCULATIONAHA.120.047375","article-title":"BMP9 and BMP10 act directly on vascular smooth muscle cells for generation and maintenance of the contractile state","volume":"143","year":"2021","journal-title":"Circulation"},{"key":"2024062609405458900_BST-2023-1547CC64","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1164\/rccm.201807-1236OC","article-title":"Bone morphogenetic protein 9 is a mechanistic biomarker of portopulmonary hypertension","volume":"199","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2024062609405458900_BST-2023-1547CC65","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/ATVBAHA.119.313357","article-title":"Endothelial BMPR2 loss drives a proliferative response to BMP (bone morphogenetic protein) 9 via prolonged canonical signaling","volume":"40","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2024062609405458900_BST-2023-1547CC66","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10456-020-09741-x","article-title":"Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cells","volume":"23","year":"2020","journal-title":"Angiogenesis"},{"key":"2024062609405458900_BST-2023-1547CC67","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/dvdy.478","article-title":"An emerging class of new therapeutics targeting TGF, Activin, and BMP ligands in pulmonary arterial hypertension","volume":"252","year":"2022","journal-title":"Dev. Dyn."},{"key":"2024062609405458900_BST-2023-1547CC68","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/dvdy.395","article-title":"BMP9 and BMP10: two close vascular quiescence partners that stand out","volume":"251","year":"2022","journal-title":"Dev. Dyn."},{"key":"2024062609405458900_BST-2023-1547CC69","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","article-title":"TGFbeta in cancer","volume":"134","year":"2008","journal-title":"Cell"},{"key":"2024062609405458900_BST-2023-1547CC70","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1056\/NEJMoa2213558","article-title":"Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension","volume":"388","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"2024062609405458900_BST-2023-1547CC71","doi-asserted-by":"publisher","first-page":"2301726","DOI":"10.1183\/13993003.01726-2023","article-title":"Viewpoint: activin signalling inhibitors for the treatment of pulmonary arterial hypertension","volume":"62","year":"2023","journal-title":"Eur. Respir. J."},{"key":"2024062609405458900_BST-2023-1547CC72","doi-asserted-by":"publisher","first-page":"eaaz5660","DOI":"10.1126\/scitranslmed.aaz5660","article-title":"ACTRIIA-Fc rebalances activin\/GDF versus BMP signaling in pulmonary hypertension","volume":"12","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"2024062609405458900_BST-2023-1547CC73","doi-asserted-by":"publisher","first-page":"7803","DOI":"10.1038\/s41598-022-11435-x","article-title":"Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertension","volume":"12","year":"2022","journal-title":"Sci. Rep."},{"key":"2024062609405458900_BST-2023-1547CC74","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1182\/blood-2006-07-034124","article-title":"Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells","volume":"109","year":"2007","journal-title":"Blood"},{"key":"2024062609405458900_BST-2023-1547CC75","doi-asserted-by":"publisher","first-page":"e78197","DOI":"10.7554\/eLife.78197","article-title":"The orphan ligand, activin C, signals through activin receptor-like kinase 7","volume":"11","year":"2022","journal-title":"Elife"},{"key":"2024062609405458900_BST-2023-1547CC76","doi-asserted-by":"publisher","first-page":"e0114954","DOI":"10.1371\/journal.pone.0114954","article-title":"Human Cerberus prevents nodal-receptor binding, inhibits nodal signaling, and suppresses nodal-mediated phenotypes","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"2024062609405458900_BST-2023-1547CC77","doi-asserted-by":"publisher","first-page":"10792","DOI":"10.1074\/jbc.M115.713487","article-title":"Transforming growth factor-beta family ligands can function as antagonists by competing for type II receptor binding","volume":"291","year":"2016","journal-title":"J. Biol. Chem."},{"key":"2024062609405458900_BST-2023-1547CC78","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/s1097-2765(03)00094-7","article-title":"The BMP7\/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly","volume":"11","year":"2003","journal-title":"Mol. Cell"},{"key":"2024062609405458900_BST-2023-1547CC79","doi-asserted-by":"publisher","first-page":"102076","DOI":"10.1016\/j.jbc.2022.102076","article-title":"Type II BMP and activin receptors BMPR2 and ACVR2A share a conserved mode of growth factor recognition","volume":"298","year":"2022","journal-title":"J. Biol. Chem."},{"key":"2024062609405458900_BST-2023-1547CC80","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12915-023-01522-4","article-title":"Formation and characterization of BMP2\/GDF5 and BMP4\/GDF5 heterodimers","volume":"21","year":"2023","journal-title":"BMC Biol."},{"key":"2024062609405458900_BST-2023-1547CC81","doi-asserted-by":"publisher","first-page":"7643","DOI":"10.1073\/pnas.0602558103","article-title":"Structure of the ternary signaling complex of a TGF-beta superfamily member","volume":"103","year":"2006","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2024062609405458900_BST-2023-1547CC82","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ab.2016.06.025","article-title":"Determination of half-maximal inhibitory concentration using biosensor-based protein interaction analysis","volume":"508","year":"2016","journal-title":"Anal. Biochem."},{"key":"2024062609405458900_BST-2023-1547CC83","doi-asserted-by":"publisher","first-page":"27313","DOI":"10.1074\/jbc.M112.377960","article-title":"Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex","volume":"287","year":"2012","journal-title":"J. Biol. Chem."},{"key":"2024062609405458900_BST-2023-1547CC84","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1161\/CIRCULATIONAHA.122.061501","article-title":"Serum and pulmonary expression profiles of the activin signaling system in pulmonary arterial hypertension","volume":"147","year":"2023","journal-title":"Circulation"},{"key":"2024062609405458900_BST-2023-1547CC85","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41467-021-21961-3","article-title":"An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension","volume":"12","year":"2021","journal-title":"Nat. Commun."},{"key":"2024062609405458900_BST-2023-1547CC86","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12964-015-0104-z","article-title":"Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B","volume":"13","year":"2015","journal-title":"Cell Commun. Signal."},{"key":"2024062609405458900_BST-2023-1547CC87","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1042\/BST20180137","article-title":"Advances in the molecular regulation of endothelial BMP9 signalling complexes and implications for cardiovascular disease","volume":"47","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"2024062609405458900_BST-2023-1547CC88","doi-asserted-by":"publisher","first-page":"jcs213512","DOI":"10.1242\/jcs.213512","article-title":"BMPR2 inhibits activin and BMP signaling via wild-type ALK2","volume":"131","year":"2018","journal-title":"J. Cell Sci."},{"key":"2024062609405458900_BST-2023-1547CC89","doi-asserted-by":"publisher","first-page":"e54582","DOI":"10.7554\/eLife.54582","article-title":"Activin A forms a non-signaling complex with ACVR1 and type II Activin\/BMP receptors via its finger 2 tip loop","volume":"9","year":"2020","journal-title":"Elife"},{"key":"2024062609405458900_BST-2023-1547CC90","doi-asserted-by":"publisher","first-page":"17800","DOI":"10.1073\/pnas.1816661116","article-title":"Role of soluble endoglin in BMP9 signaling","volume":"116","year":"2019","journal-title":"Proc. Natl Acad. Sci. U.S.A."}],"container-title":["Biochemical Society Transactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/52\/3\/1515\/958320\/bst-2023-1547c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/52\/3\/1515\/958320\/bst-2023-1547c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T09:41:13Z","timestamp":1719394873000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article\/52\/3\/1515\/234420\/Bone-morphogenetic-protein-signalling-in-pulmonary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,8]]},"references-count":90,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,5,8]]},"published-print":{"date-parts":[[2024,6,26]]}},"URL":"https:\/\/doi.org\/10.1042\/bst20231547","relation":{},"ISSN":["0300-5127","1470-8752"],"issn-type":[{"value":"0300-5127","type":"print"},{"value":"1470-8752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,8]]}}}